Guardant Health
GH
#3905
Rank
$2.32 B
Marketcap
$19.08
Share price
6.21%
Change (1 day)
-21.60%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of March 2024 (TTM): 3.88

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.87618. At the end of 2023 the company had a P/S ratio of 5.82.

P/S ratio history for Guardant Health from 2018 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.64-6.00%๐Ÿ‡บ๐Ÿ‡ธ USA
10.1 160.32%๐Ÿ‡บ๐Ÿ‡ธ USA